(Q33831259)

English

Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

Cremieux PY

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Finkelstein SN

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Berndt ER

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Crawford J

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Slavin MB

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5 Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

459-472

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

https://scigraph.springernature.com/pub.10.2165/00019053-199916050-00004

0 references

Accounting for future costs in medical cost-effectiveness analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomics: state of the art in 1997.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The application of sample selection models to outcomes research: the case of evaluating the effects of antidepressant therapy on resource utilization

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comment: cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What are cancer patients willing to pay for prophylactic epoetin alfa? A cost-benefit analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The validity of a visual analogue scale in determining social utility weights for health states

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Healthy-years equivalents versus quality-adjusted life years: in pursuit of progress.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfusion requirements, risks, and costs for patients with malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The problem of quality of life in medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical applications of visual analogue scales: a critical review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs of blood transfusion: a process-flow analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythropoietin for anaemia in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10662393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-199916050-00004

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33831259&oldid=1622625911"